CNSYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERENOME, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.05 (-2.94%)
Close on Oct 19, 2026
- Market cap
- $11.38M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 2, 2026 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Apr 1, 2026 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Aug 14, 2023(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 1, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 6, 2019 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Aug 5, 2019 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 24, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 23, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 12, 2016 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 10, 2016 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |